甲状旁腺激素的成骨机制及其对颅颌面和牙周组织再生的研究进展

›› 2015, Vol. 35 ›› Issue (12): 1076-1079.

甲状旁腺激素的成骨机制及其对颅颌面和牙周组织再生的研究进展

王芳¹,葛少华²

1. 山东省口腔组织再生重点实验室，山东大学口腔医学院牙周科，山东济南
2. 山东大学口腔医学院

收稿日期:2015-06-02 修回日期:2015-07-10 出版日期:2015-12-28 发布日期:2015-12-15
通讯作者: 葛少华 E-mail:shaohuage@sdu.edu.cn

Research progress on the osteogenic mechanisms of parathyroid hormone and its effect on craniomaxillofacial and periodontal tissue regeneration

Fang WANG¹,

Received:2015-06-02 Revised:2015-07-10 Online:2015-12-28 Published:2015-12-15

摘要/Abstract

摘要： 对于口腔颌面部疾病导致的组织缺损，传统治疗方法大多为赝复体修复或骨移植，但其有很多弊端，如可引起感染或炎症、造成供区继发性损伤等。近年来，随着原位组织工程技术的发展，许多研究者开始尝试通过各种方法诱导缺损组织局部细胞发生迁移、增殖与分化，形成新生组织，从而实现口腔颌面部组织再生。甲状旁腺激素（parathyroid hormone，PTH）作为唯一得到美国FDA批准的用于治疗骨质疏松的骨合成代谢药物，能够促进骨祖细胞的增殖和分化，是骨形成和骨重建过程中的一个重要调节因子。该文综述了甲状旁腺激素的成骨机制及其对颅颌面及牙周组织再生的作用。

关键词: 甲状旁腺激素, 成骨机制, 颅颌面骨再生, 牙周组织再生

Abstract: The traditional treatments of tissue defects caused by oral and craniomaxillofacial diseases are obturator prosthesis or bone transplantation,which have many drawbacks,such as infection and inflammation,secondary damage of the donor site,etc.In recent years,with the development of in situ tissue engineering technique,some researchers have begun to try various methods to induce cells within the local defect site to migrate,proliferate and differentiate,which may result in new tissue formation,thus achieving oral and craniomaxillofacial tissue regeneration.Approved by the FDA,parathyroid hormone（PTH） is the unique bone anabolic drug for the treatment of osteoporosis,which is seen as an important regulatory factor in the process of bone formation and bone remodeling that can promote the proliferation and differentiation of bone progenitor cells.This article reviewed the mechanisms of parathyroid hormone on osteogenesis and its impact on craniomaxillofacial and periodontal tissue regeneration.

Key words: parathyroid hormone, osteogenic mechanisms, craniomaxillofacial bone regeneration, periodontal tissue regeneration

中图分类号:

R780.2
Q573

王芳葛少华. 甲状旁腺激素的成骨机制及其对颅颌面和牙周组织再生的研究进展[J]. , 2015, 35(12): 1076-1079.

Fang WANG. Research progress on the osteogenic mechanisms of parathyroid hormone and its effect on craniomaxillofacial and periodontal tissue regeneration[J]. , 2015, 35(12): 1076-1079.

参考文献

[1] Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures[J]. Clin Invest, 2008, 118(2): 421-428.
[2] Marx UC, Adermann K, Bayer P,et al. Solution structures of human parathyroid hormone fragments hPTH(1-34) and hPTH(1-39) and bovine parathyroid hormone fragment bPTH(1-37)[J]. Biochem Biophys Res Commun, 2000, 267(1): 213-220.
[3] Frisch SM. cAMP takes controls[J]. Nat Cell Biol, 2000, 2(9): E167-E168.
[4] Migliaccio S, Brama M, Malavolta N. Management of glucocorticoids-induced osteoporosis: role of teriparatide[J]. Ther Clin Risk Manag, 2009, 5(2): 305-310.
[5] Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH[J]. Bone, 2007, 40(6): 1434-1446.
[6] Drake MT, Srinivasan B, M?dder UI, et al. Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women[J]. Bone, 2011, 49(3): 349-355.
[7] Tam CS, Heersche JN, Murray TM, et al. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration[J]. Endocrinology, 1982, 110(2): 506-512.
[8] Demiralp B, Chen H, Koh-Paige AJ, et al. Anabolic effects of parathyroid hormone during endochondral bone growth are dependent on c-fos[J]. Endocrinology, 2002, 143(10): 4038-4047.
[9] Tokunaga K, Seto H, Ohba H, et al. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis[J]. Periodontal Res, 2011, 46(6): 655–662.
[10] Miller SC, Hunziker J, Mecham M, et al. Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats[J]. Dent Res, 1997, 76(8): 1471-1476.
[11] Tsai KY, Huang CS, Huang GM, et al. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw[J]. Rheumatol, 2010, 37(3): 675.
[12] Tang ZL, Zhang WJ, Wang DX, et al.An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone[J]. Oral Maxillofac Surg, 2014, 72(2):419-430.
[13] Gabet Y, Muller R, Levy J, et al. Parathyroid hormone(1-34) enhances titanium implant anchorage in low-density trabecular bone: A correlative micro-compute tomographic and biomechanical analysis[J]. Bone, 2006, 39(2): 276-282.
[14] Neer M, Slovick DM, Daly M, Potts T Jr,?Nussbaum SR. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol [M]Christiansen C, Overgaard K(Eds). Osteoporosis. Copenhagen: Osteopress, 1990. 1314-1317.
[15] Zhang L, Takahashi HE, Inoue J, et al. Effects of intermittent administration of low does human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles[J]. Bone, 1997, 21(6): 501-506.
[16] Mashiba T, Burr DB, Turner CH, et al. Effects of human parathyroid hormone(1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits[J]. Bone, 2001, 28(5): 538-547.
[17] Li F, Li GF, Hu HK, et al. Effect of parathyroid hormone on experimental tooth movement in rats[J]. Orthod Dentofacial Orthop, 2013, 144(4): 523-532.
[18] Yao SM, Pan FM, Wise GE. Chronologicsl gene expression of parathyroid hormone-related protein(PTHrp) in the stellate reticulum of the rat-implications for tooth eruption[J]. Oral Biol, 2007, 52(3):228-232.
[19] Ouyang H, McCauley LK, Berry JE, et al. Parathyroid hormone-related protein regulates extracellular matrix gene expression in cementoblasts and inhibits cementoblast-mediated mineralization in vitro[J]. Bone Miner Res, 2000, 15(11): 2140-2153.
[20] King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review[J]. Periodontol, 2002, 73(8): 925-936.
[21] Wolf M, Lossdorfer S, Abuduwali N, et al. Effect of Intermittent PTH(1–34) on Human Periodontal Ligament Cells Transplanted into Immunocompromised Mice[J]. Tissue Eng Part A, 2012, 18(17-18):1849-1856.
[22]Barros SP, Silva MA, Somerman MJ, et al. Parathyroid hormone protects periodontitis-associated bone loss[J]. Dent Res, 2003, 82(10): 791–795.
[23] Marques MR, da Silva MA, Manzi FR, et al. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats[J]. Arch Oral Biol, 2005, 50(4): 421-429.
[24] Bashutski JD, Eber RM, Kinney JS, et al. Teriparatide and osseous regeneration in the oral cavity[J]. N Engl J Med, 2010, 363(25): 2396-2405